Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon
The inventive polypeptide is embodied in the form of a similar fragment of the epidermal growth factor of aminoacid ranging from 21 to 31 and capable of efficiently binding with the receptor of the epidermal growth factor as a vector for the directed supply of anticancer agent to tumour cells. The i...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | NATALYA BORISOVNA FELDMAN SERGEY VIKTOROVICH LUTSENKO EVGENIY SERGEEVICH SEVERIN SERGEY EVGENYEVICH SEVERIN SERGEY MICHAILOVICH KISELEV |
| description | The inventive polypeptide is embodied in the form of a similar fragment of the epidermal growth factor of aminoacid ranging from 21 to 31 and capable of efficiently binding with the receptor of the epidermal growth factor as a vector for the directed supply of anticancer agent to tumour cells. The inventive conjugate of said polypeptide contains doxorubicine and has a selective action on cancer tumours and can substantially reduce the resistance of tumour cells with respect to the anticancer agents, the conjugated parts of said agents being binded with the aid of a chemical bond which is unstable in relation to acid hydrolysis. The inventive pharmaceutical composition comprises an efficient quantity of conjugate and a carrier which is fit for intravenous injection. Said invention can be used for medicine for treating cancer patients. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2002362210BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2002362210BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2002362210BB23</originalsourceid><addsrcrecordid>eNqNjDEOgkAQRWksjHqHKSw1wSWxB6OxtNCaDLsDjIGZDbskensh4QBWP-_n5a0Tfmj39eQjOzpAbAmsyntsMNJMA2k9PxFZWBpw-tFhrNiyEKA4QPAtDj1aGiNb7Ca59xo4sgpUGMgtGdkmqxq7QLtlN8n-dn1e7kfyWlLwU0IolvnLpKnJzsac0qIw2Z_aD0PGQss</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon</title><source>esp@cenet</source><creator>NATALYA BORISOVNA FELDMAN ; SERGEY VIKTOROVICH LUTSENKO ; EVGENIY SERGEEVICH SEVERIN ; SERGEY EVGENYEVICH SEVERIN ; SERGEY MICHAILOVICH KISELEV</creator><creatorcontrib>NATALYA BORISOVNA FELDMAN ; SERGEY VIKTOROVICH LUTSENKO ; EVGENIY SERGEEVICH SEVERIN ; SERGEY EVGENYEVICH SEVERIN ; SERGEY MICHAILOVICH KISELEV</creatorcontrib><description>The inventive polypeptide is embodied in the form of a similar fragment of the epidermal growth factor of aminoacid ranging from 21 to 31 and capable of efficiently binding with the receptor of the epidermal growth factor as a vector for the directed supply of anticancer agent to tumour cells. The inventive conjugate of said polypeptide contains doxorubicine and has a selective action on cancer tumours and can substantially reduce the resistance of tumour cells with respect to the anticancer agents, the conjugated parts of said agents being binded with the aid of a chemical bond which is unstable in relation to acid hydrolysis. The inventive pharmaceutical composition comprises an efficient quantity of conjugate and a carrier which is fit for intravenous injection. Said invention can be used for medicine for treating cancer patients.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080403&DB=EPODOC&CC=AU&NR=2002362210B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080403&DB=EPODOC&CC=AU&NR=2002362210B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NATALYA BORISOVNA FELDMAN</creatorcontrib><creatorcontrib>SERGEY VIKTOROVICH LUTSENKO</creatorcontrib><creatorcontrib>EVGENIY SERGEEVICH SEVERIN</creatorcontrib><creatorcontrib>SERGEY EVGENYEVICH SEVERIN</creatorcontrib><creatorcontrib>SERGEY MICHAILOVICH KISELEV</creatorcontrib><title>Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon</title><description>The inventive polypeptide is embodied in the form of a similar fragment of the epidermal growth factor of aminoacid ranging from 21 to 31 and capable of efficiently binding with the receptor of the epidermal growth factor as a vector for the directed supply of anticancer agent to tumour cells. The inventive conjugate of said polypeptide contains doxorubicine and has a selective action on cancer tumours and can substantially reduce the resistance of tumour cells with respect to the anticancer agents, the conjugated parts of said agents being binded with the aid of a chemical bond which is unstable in relation to acid hydrolysis. The inventive pharmaceutical composition comprises an efficient quantity of conjugate and a carrier which is fit for intravenous injection. Said invention can be used for medicine for treating cancer patients.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEOgkAQRWksjHqHKSw1wSWxB6OxtNCaDLsDjIGZDbskensh4QBWP-_n5a0Tfmj39eQjOzpAbAmsyntsMNJMA2k9PxFZWBpw-tFhrNiyEKA4QPAtDj1aGiNb7Ca59xo4sgpUGMgtGdkmqxq7QLtlN8n-dn1e7kfyWlLwU0IolvnLpKnJzsac0qIw2Z_aD0PGQss</recordid><startdate>20080403</startdate><enddate>20080403</enddate><creator>NATALYA BORISOVNA FELDMAN</creator><creator>SERGEY VIKTOROVICH LUTSENKO</creator><creator>EVGENIY SERGEEVICH SEVERIN</creator><creator>SERGEY EVGENYEVICH SEVERIN</creator><creator>SERGEY MICHAILOVICH KISELEV</creator><scope>EVB</scope></search><sort><creationdate>20080403</creationdate><title>Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon</title><author>NATALYA BORISOVNA FELDMAN ; SERGEY VIKTOROVICH LUTSENKO ; EVGENIY SERGEEVICH SEVERIN ; SERGEY EVGENYEVICH SEVERIN ; SERGEY MICHAILOVICH KISELEV</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2002362210BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2008</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NATALYA BORISOVNA FELDMAN</creatorcontrib><creatorcontrib>SERGEY VIKTOROVICH LUTSENKO</creatorcontrib><creatorcontrib>EVGENIY SERGEEVICH SEVERIN</creatorcontrib><creatorcontrib>SERGEY EVGENYEVICH SEVERIN</creatorcontrib><creatorcontrib>SERGEY MICHAILOVICH KISELEV</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NATALYA BORISOVNA FELDMAN</au><au>SERGEY VIKTOROVICH LUTSENKO</au><au>EVGENIY SERGEEVICH SEVERIN</au><au>SERGEY EVGENYEVICH SEVERIN</au><au>SERGEY MICHAILOVICH KISELEV</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon</title><date>2008-04-03</date><risdate>2008</risdate><abstract>The inventive polypeptide is embodied in the form of a similar fragment of the epidermal growth factor of aminoacid ranging from 21 to 31 and capable of efficiently binding with the receptor of the epidermal growth factor as a vector for the directed supply of anticancer agent to tumour cells. The inventive conjugate of said polypeptide contains doxorubicine and has a selective action on cancer tumours and can substantially reduce the resistance of tumour cells with respect to the anticancer agents, the conjugated parts of said agents being binded with the aid of a chemical bond which is unstable in relation to acid hydrolysis. The inventive pharmaceutical composition comprises an efficient quantity of conjugate and a carrier which is fit for intravenous injection. Said invention can be used for medicine for treating cancer patients.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2002362210BB2 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A02%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NATALYA%20BORISOVNA%20FELDMAN&rft.date=2008-04-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2002362210BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |